Zhenlin Yang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 9
-
- Lung Cancer Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 4
- Metastasis and carcinoma case studies 2
- Co-authors
- Jie He (14 shared papers)Wei Guo (9 shared papers)Renda Li (9 shared papers)Jiachen Xu (13 shared papers)Fengwei Tan (7 shared papers)Yibo Gao (6 shared papers)Qi Xue (4 shared papers)Fei Shao (2 shared papers)
- Journals
- Nature Communications (3 papers)Frontiers in Immunology (2 papers)Translational Oncology (2 papers)EBioMedicine (2 papers)BMC Medicine (1 paper)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Zhenlin Yang
34 papers receiving 668 citations
Peers
Comparison fields: 5 of 65
- Oncology 218
- Cancer Research 115
- Pulmonary and Respiratory Medicine 186
- Immunology 106
- Molecular Biology 212
Countries citing papers authored by Zhenlin Yang
This map shows the geographic impact of Zhenlin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlin Yang more than expected).
Fields of papers citing papers by Zhenlin Yang
This network shows the impact of papers produced by Zhenlin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlin Yang. The network helps show where Zhenlin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenlin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 71 | |
| 2 | 2017 | 59 | |
| 3 | 2022 | 47 | |
| 4 | 2022 | 44 | |
| 5 | 2020 | 43 | |
| 6 | 2017 | 37 | |
| 7 | 2022 | 35 | |
| 8 | 2021 | 32 | |
| 9 | 2020 | 32 | |
| 10 | 2024 | 30 | |
| 11 | 2019 | 26 | |
| 12 | 2022 | 25 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 22 | |
| 15 | 2021 | 17 | |
| 16 | 2022 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2022 | 11 | |
| 19 | 2023 | 11 | |
| 20 | 2022 | 10 |
About Zhenlin Yang
Zhenlin Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Immunology, having authored 37 papers that have together received 673 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Metastasis and carcinoma case studies (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Oncology (218 citations), Cancer Research (115 citations), Pulmonary and Respiratory Medicine (186 citations), Immunology (106 citations) and Molecular Biology (212 citations). Zhenlin Yang has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Jie He, Wei Guo, Renda Li, Jiachen Xu, Fengwei Tan, Yibo Gao, Qi Xue, Fei Shao, Shugeng Gao and Qilin Huai. Their work appears in journals such as Nature Communications, Frontiers in Immunology, Translational Oncology, EBioMedicine and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.